FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index. Read more about FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index.
Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer. Read more about Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer.
A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone. Read more about A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial). Read more about Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
AroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens. Read more about AroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens.
Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer. Read more about Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer.
Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial. Read more about Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial.
Expression profiling of circulating tumor cells in metastatic breast cancer. Read more about Expression profiling of circulating tumor cells in metastatic breast cancer.
Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis. Read more about Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.
Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment. Read more about Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment.
